META vs NRDS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
NRDS exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and a pristine balance sheet (Debt/Equity 0.04). However, the stock is currently trading at a premium to both its Graham Number ($8.7) and Intrinsic Value ($4.48). While revenue growth remains robust at 22.6%, a severe collapse in earnings growth (-62.5%) and consistent earnings misses create a significant fundamental disconnect. The combination of bearish insider activity and a poor earnings track record offsets the strong liquidity and low valuation multiples.
Compare Another Pair
Related Comparisons
META vs NRDS: Head-to-Head Comparison
This page compares Meta Platforms, Inc. (META) and NerdWallet, Inc. (NRDS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.